BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8636365)

  • 1. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
    Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan.
    Takeshita A; Nagayama Y; Yokoyama N; Ishikawa N; Ito K; Yamashita T; Obara T; Murakami Y; Kuma K; Takamatsu J
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2607-11. PubMed ID: 7673402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
    Nogueira CR; Kopp P; Arseven OK; Santos CL; Jameson JL; Medeiros-Neto G
    Thyroid; 1999 Nov; 9(11):1063-8. PubMed ID: 10595453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan.
    Tanaka K; Nagayama Y; Takeshita A; Namba H; Yamashita S; Niwa M; Nagataki S
    Thyroid; 1996 Jun; 6(3):195-9. PubMed ID: 8837326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid.
    Paschke R; Tonacchera M; Van Sande J; Parma J; Vassart G
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1785-9. PubMed ID: 7989485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating mutations of the TSH receptor in differentiated thyroid carcinomas.
    Russo D; Arturi F; Schlumberger M; Caillou B; Monier R; Filetti S; Suárez HG
    Oncogene; 1995 Nov; 11(9):1907-11. PubMed ID: 7478621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G
    Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
    Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA; Wicker R; Crespo P; Russo D; Filetti S; Gutkind JS; Sarasin A; Suárez HG
    Oncogene; 2000 Oct; 19(42):4896-905. PubMed ID: 11039907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy.
    Porcellini A; Ciullo I; Laviola L; Amabile G; Fenzi G; Avvedimento VE
    J Clin Endocrinol Metab; 1994 Aug; 79(2):657-61. PubMed ID: 8045989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation.
    Spambalg D; Sharifi N; Elisei R; Gross JL; Medeiros-Neto G; Fagin JA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3898-901. PubMed ID: 8923835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas.
    Kamiya Y; Murakami M; Yanagita Y; Koitabashi H; Nagamachi Y; Hosoi Y; Ogiwara T; Mizuma H; Iriuchijima T; Mori M
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):137-42. PubMed ID: 9685222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations in the VI transmembrane segment of the thyrotropin receptor constitutively activate cAMP signalling in thyroid hyperfunctioning adenomas.
    Porcellini A; Ciullo I; Pannain S; Fenzi G; Avvedimento E
    Oncogene; 1995 Sep; 11(6):1089-93. PubMed ID: 7566968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Point mutations of the thyrotropin receptor gene in autonomously functioning thyroid gland nodules: correlation with clinical findings and morphology].
    Lax SF; Semlitsch G; Schauer S; Zatloukal K; Langsteger W; Eber O; Höfler G
    Verh Dtsch Ges Pathol; 1997; 81():145-50. PubMed ID: 9474865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G protein and thyrotropin receptor mutations in thyroid neoplasia.
    Esapa C; Foster S; Johnson S; Jameson JL; Kendall-Taylor P; Harris PE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):493-6. PubMed ID: 9024242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions.
    Arturi F; Scarpelli D; Coco A; Sacco R; Bruno R; Filetti S; Russo D
    Thyroid; 2003 Apr; 13(4):341-3. PubMed ID: 12804102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.